Optic Nerve Sheath Diameter and Intracranial Pressure (ICP) in Children
Determining the Correlation of Optic Nerve Sheath Diameter With Intracranial Pressure in Children
1 other identifier
observational
N/A
0 countries
N/A
Brief Summary
The use of optic nerve sheath diameter (ONSD) measurements as a non invasive test for raised ICP has many potential benefits. This includes having assessments that can be made at the bedside instead of requiring patient transport to CT or MRI, which in itself can cause a rise in ICP. If ONSD represents an acute and sensitive measurement of elevated ICP, it may prove useful in the emergency department (ED) setting in the evaluation of shunts used for cerebrospinal fluid (CSF) diversion. The investigators hypothesize that ONSD will correlate with measured ICP and thus be a reliable tool for the bedside assessment of ICP. The investigators further hypothesize that ONSD changes will correlate with changes in ICP, making it a useful bedside tool for assessing ICP changes over time. This is a prospective, observational study using a convenience sample. Children who are 0 - 18 years old who have an invasive intracranial ICP monitoring device admitted to the hospital Pediatric Intensive Care Unit (PICU) are eligible for participation in the study. Children who are 0-18 years old who are determined to require a shunt revision following evaluation in the ED will also be included in the study. 10. After the invasive intracranial pressure monitoring device is placed, for every recruited patient, ONSD measurements will be taken and the ICP will be recorded 8 hours post placement and then repeated 3 times a day until the intracranial pressure monitoring device is removed.12. For ventriculoperitoneal (VP) shunt revision patients, the investigators will obtain a measurement just before surgery, immediately post-op, and then 12 hours, 24 hours, and 36 hours post-op. If the patient is otherwise ready for discharge prior to 36 hours, the measurement may be omitted or done early so as to not unnecessarily prolong the hospitalization
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jul 2016
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 18, 2015
CompletedFirst Posted
Study publicly available on registry
July 23, 2015
CompletedStudy Start
First participant enrolled
July 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2018
CompletedMay 24, 2017
May 1, 2017
2.1 years
July 18, 2015
May 22, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
The correlation (composite of multiple measurements) of ONSD measurements by sonography in patients with intracranial pressure measurements by invasive intracranial monitors.
3 years
Secondary Outcomes (1)
ONSD measurements by sonography in patients with VP shunt malfunction as evidenced by CT scan
3 years
Study Arms (1)
study subjects
Patients age 0-18 with intracranial monitoring devices in place or requiring a VP shunt revision who receive a ocular ultrasound evaluating ONSD
Interventions
Ocular ultrasound to look at the optic nerve sheath diameter in patients with an intracranial monitoring device or with a ventriculoperitoneal shunt malfunction requiring revision
Eligibility Criteria
Children who are 0 - 18 years old who have an invasive intracranial ICP monitoring device admitted to PICU and children who are 0-18 years old who are determined to require a shunt revision following evaluation in the ED.
You may qualify if:
- Children between 0 years and 18 years of age
- Children who are determined to need an invasive intracranial monitoring device in the ED and admitted to the PICU
- Children who undergo VP shunt revisions at the study site
You may not qualify if:
- Children with an invasive intracranial monitoring device that is malfunctioning
- Prior adverse reactions to ultrasound gel
- Pre-existing ophthalmologic conditions that could cause a baseline increase in ONSD, including glaucoma or severe ocular trauma
- Children with ocular or facial trauma that would impede ONSD measurements
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Anna Romingerlead
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Anna H Rominger, MD MPH MsC
University of Louisville
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
July 18, 2015
First Posted
July 23, 2015
Study Start
July 1, 2016
Primary Completion
August 1, 2018
Study Completion
August 1, 2018
Last Updated
May 24, 2017
Record last verified: 2017-05
Data Sharing
- IPD Sharing
- Will not share